Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy
Molecules · 2023
DOI: 10.3390/molecules28093824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Lei Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Medicine and Functional Food Characteristic Subject Project in Heilongjiang Province, Natural Science Foundation of Heilongjiang Province of China, Heilongjiang Postdoctoral Foundation.
Abstract (Originalsprache)
In this work, glucose transporter-1 (GLUT-1) and glutathione (GSH) over-expression in liver cancer was utilized to design a reduction-responsive and active targeting drug delivery system AG-PEG-SS-PCL (APSP) for the delivery of sorafenib (SF). The SF-APSP micelles were prepared using the thin film hydration method and characterized by various techniques. In vitro release experiments showed that the cumulative release of SF-APSP micelles in the simulated tumor microenvironment (pH 7.4 with GSH) reached 94.76 ± 1.78% at 48 h, while it was only 20.32 ± 1.67% in the normal physiological environment (pH 7.4 without GSH). The in vitro study revealed that glucosamine (AG) enhanced the antitumor effects of SF, and SF-APSP micelles inhibited proliferation by targeting HepG2 cells and suppressing cyclin D1 expression. The in vivo antitumor efficacy study further confirmed that the SF-APSP micelles had excellent antitumor effects and better tolerance against nude mouse with HepG2 cells than other treatment groups. All in all, these results indicated that SF-APSP micelles could be a promising drug delivery system for anti-hepatoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Jiamusi University, Jiamusi 154007, China.
ORCID-Profile: Weitong Sun
Förderung
- North Medicine and Functional Food Characteristic Subject Project in Heilongjiang Province
- Natural Science Foundation of Heilongjiang Province of China
- Heilongjiang Postdoctoral Foundation
- Provincial Undergraduate Colleges Basal Research Foundation
- Doctoral Scientific Research Startup Fund
- Heilongjiang Provincial Key Laboratory of New Drug Development and Pharmacotoxicological Evaluation
- College Students’ Innovation and Entrepreneurship Training Program
Zitieren
APA
Meng, L., Liu, F., Du, C., Zhu, J., Xiong, Q., Li, J., & Sun, W. (2023). Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy. Molecules. https://doi.org/10.3390/molecules28093824
Vancouver
Meng L, Liu F, Du C, Zhu J, Xiong Q, Li J, et al. Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy. Molecules. 2023. doi:10.3390/molecules28093824
BibTeX
@article{Meng2023,
author = {Meng, Lei and Liu, Fangshu and Du, Chenchen and Zhu, Jiaying and Xiong, Qian and Li, Jing and Sun, Weitong},
title = {Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28093824}
}
EUVIMED